Rodney Rocconi, M.D., gynecologic oncologist at USA Health Mitchell Cancer Institute and professor of gynecologic oncology at the USA College of Medicine, will present his research on ovarian cancer in a webinar entitled “Front Line Ovarian Cancer: Turning up the Heat on Immunotherapy” on Thursday, May 14.
Rocconi’s research found that vaccines made from patients’ own tumors could prolong the lives of women with ovarian cancer, particularly those without a BRCA gene mutation. The presentation is one of four pre-recorded sessions to be aired during the webinar. Rocconi and other researchers will answer participants’ questions live via Zoom teleconferencing.
The SGO meeting, which had been planned for March 28-31 in Toronto, was cancelled after large gatherings were banned because of the COVID-19 pandemic. Members were invited to register for webinars to learn about selected research findings.
Uterine cancer research co-authored by Nate Jones, M.D., gynecologic oncologist at the Mitchell Cancer Institute and assistant professor of gynecologic oncology at the USA College of Medicine, had been slated for oral presentation at the meeting. The study identified differences in certain molecular profiles of uterine cancer between African American and Caucasian patients. The research findings are expected to be posted online or presented at a later date, according to the SGO.
